APA (7th ed.) Citation

Piccini, J. P., & Hacke, W. (2016). Polypharmacy and the efficacy and safety of rivaroxaban versus warfarin in the prevention of stroke in patients with nonvalvular atrial fibrillation. Circulation, 133(4), . https://doi.org/10.1161/CIRCULATIONAHA.115.018544

Chicago Style (17th ed.) Citation

Piccini, Jonathan P., and Werner Hacke. "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation." Circulation 133, no. 4 (2016). https://doi.org/10.1161/CIRCULATIONAHA.115.018544.

MLA (9th ed.) Citation

Piccini, Jonathan P., and Werner Hacke. "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation." Circulation, vol. 133, no. 4, 2016, https://doi.org/10.1161/CIRCULATIONAHA.115.018544.